The reality of your patient panel: Many psychiatric medications cause significant weight gain (atypical antipsychotics, mood stabilizers, certain antidepressants) Obesity itself worsens depression, anxiety, and self-esteem Type 2 diabetes and metabolic syndrome are 2-3x more common in people with serious mental illness Youre already monitoring metabolic labs (glucose, lipids, A1c) for patients on psychiatric meds
It promotes hair thickening and is effective for both men and women experiencing hair loss and scalp issues such as dandruff, dryness, oiliness, and psoriasis
The company teased data for efinopegdutide, a GLP-1/glucagon receptor co-agonist, in nonalcoholic steatohepatitis compared to Novo Nordisks semaglutide, which is not yet approved for NASH
Wegovy is approved as a weight-loss drug for people ages 12 and up with obesity and for some adults who are categorized as overweight but not obese
545, 591 Lallouet, M